GAMMA Investing LLC Has $317,000 Stake in Amedisys, Inc. (NASDAQ:AMED)

GAMMA Investing LLC boosted its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 3,507.4% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,427 shares of the health services provider's stock after purchasing an additional 3,332 shares during the period. GAMMA Investing LLC's holdings in Amedisys were worth $317,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Empowered Funds LLC bought a new stake in Amedisys during the fourth quarter worth $318,000. Blue Trust Inc. increased its stake in shares of Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after purchasing an additional 124 shares during the last quarter. Rhumbline Advisers raised its holdings in shares of Amedisys by 1.6% in the 4th quarter. Rhumbline Advisers now owns 91,298 shares of the health services provider's stock valued at $8,289,000 after purchasing an additional 1,412 shares during the period. State of New Jersey Common Pension Fund D lifted its stake in Amedisys by 14.6% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 23,324 shares of the health services provider's stock valued at $2,118,000 after purchasing an additional 2,967 shares during the last quarter. Finally, Venturi Wealth Management LLC grew its holdings in Amedisys by 397.4% during the fourth quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock worth $89,000 after purchasing an additional 779 shares during the period. 94.36% of the stock is currently owned by institutional investors.

Amedisys Stock Performance

Shares of Amedisys stock traded down $0.19 on Tuesday, hitting $97.65. The stock had a trading volume of 201,713 shares, compared to its average volume of 418,413. The stock has a market cap of $3.20 billion, a price-to-earnings ratio of 36.03, a price-to-earnings-growth ratio of 1.32 and a beta of 0.94. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.27. Amedisys, Inc. has a twelve month low of $82.15 and a twelve month high of $98.95. The business's 50 day moving average is $94.79 and its two-hundred day moving average is $92.36.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. The firm had revenue of $594.78 million for the quarter, compared to analyst estimates of $597.43 million. Amedisys had a return on equity of 12.52% and a net margin of 3.79%. The company's revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.03 EPS. Analysts forecast that Amedisys, Inc. will post 4.4 EPS for the current year.

Analysts Set New Price Targets

AMED has been the topic of several research analyst reports. Stephens restated an "equal weight" rating and issued a $101.00 price objective on shares of Amedisys in a research note on Tuesday, March 4th. Wall Street Zen cut Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and set a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.